EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Radiotherapy in the Management of Melanoma Brain Metastases: An Overview

Marko Lens, Jacob Schachter

Current Treatment Options in Oncology · 2025

DOI: 10.1007/s11864-024-01289-y ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Treatment Options in Oncology, 2025. Verfasst von Marko Lens und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Leeds, Beckett Street, Leeds, LS9 7TF, UK. markolens@aol.com. Hauptthemen laut MEDLINE: Melanoma, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Opinion statement Clinical management of melanoma brain metastases is complex and requires multidisciplinary approach. With close collaboration between neurosurgeons, radiation oncologists and medical oncologists, melanoma patients with brain are offered different treatment modalities: surgery, radiation therapy, systemic therapy or combined treatments. Radiation therapy (whole brain radiotherapy- WBRT and stereotactic radiosurgery- SRS) is an integral part of treating melanoma brain metastases. Use of immunotherapy (checkpoint inhibitors) and targeted therapy (BRAF/MEK inhibitors) significantly changed the outcome in patients with melanoma metastases. Currently, ipilimumab and nivolumab (COMBO) is the preferred first-line systemic therapy for all patients with asymptomatic brain metastases, regardless of BRAF status (BRAF wild-type and BRAF-mutated). Although at the moment there is no consensus on the concomitant use of SRS and COMBO, results from clinical trials suggest that this combined treatment modality should be considered the standard of care for melanoma patients with brain metastases. However, further clinical research is required to define optimal treatment modalities for routine management of melanoma brain lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaBrain NeoplasmsHumansDisease ManagementCombined Modality TherapyTreatment OutcomeRadiosurgery

Stichwörter der Autor:innen

Brain metastasesMelanomaRadiationStereotactic radiosurgery

Autor:innen und Institutionen

  • University of Leeds, Beckett Street, Leeds, LS9 7TF, UK. markolens@aol.com.
  • Ella Lemelbaum Institute for Immuno Oncology, Chaim Sheba Medical Center, 6997801, Tel Aviv, Israel.

Zitieren

APA

Lens, M., & Schachter, J. (2025). The Role of Radiotherapy in the Management of Melanoma Brain Metastases: An Overview. Current Treatment Options in Oncology. https://doi.org/10.1007/s11864-024-01289-y

Vancouver

Lens M, Schachter J. The Role of Radiotherapy in the Management of Melanoma Brain Metastases: An Overview. Current Treatment Options in Oncology. 2025. doi:10.1007/s11864-024-01289-y

BibTeX
@article{Lens2025,
  author = {Lens, Marko and Schachter, Jacob},
  title = {The Role of Radiotherapy in the Management of Melanoma Brain Metastases: An Overview},
  journal = {Current Treatment Options in Oncology},
  year = {2025},
  doi = {10.1007/s11864-024-01289-y}
}
Kostenlos starten →